The Pharma Legal Handbook: Colombia

Colombia is one of Latin America's largest pharmaceutical markets and the primary entry point for companies building a broader Andean and Pacific Alliance regional presence. INVIMA, the national medicines regulatory authority, manages product registration and post-market surveillance, while the Ministry of Health oversees pricing through a system that has been subject to significant reform.

Colombia's pricing framework includes both a controlled price regime for essential medicines and a monitored price regime for other products, with the National Drug Price Commission setting reference prices based on international benchmarks. The public health system and the extensive use of managed care organisations create a complex market access environment that requires specific expertise.

The Pharma Legal Handbook: Colombia provides a comprehensive reference for pharmaceutical regulation in Colombia, covering INVIMA product registration, pricing frameworks, clinical trial requirements, pharmacovigilance obligations, manufacturing standards, marketing and promotional rules, and intellectual property protection.

If legal handbook content is updated, you will receive an updated PDF free for up to one year after purchase.